The APPG's aim is to see effective NHS implementation of useful scientific and technological ​innovations that support delivery of more personalised and sustainable healthcare, for the benefit of patients and the wider population. We will undertake ​a focused programme of activities, ​involving patients at every possible opportunity, and ​regularly publish updates and progress reports on our work.

  • 13/03/2017

    Opportunities for more personalised lung cancer care

    by Stefano Gortana

    Bringing together parliamentarians and a wide range of experts from the clinical, academic and public sectors, the meeting of the All-Party Parliamentary Group on Personalised Medicine on 28 February 2017 examined patient needs and scientific opportunities for more personalised care for lung cancer.

  • 01/09/2016

    Why the use of technology in healthcare is truly mind-blowing

    by Liz Mear (Northern Health Science Alliance)

    I love technology but my 18-year old frequently tells me off for using it like a granny – his words not mine, sorry to all tech-whiz grannies out there.

  • 03/08/2016

    Personalised medicine - how to stand out in a crowd

    by Sarion Bowers (The Wellcome Trust Sanger Institute)

    No two human beings are the same. Each one of us is a completely unique individual and because the DNA we inherit at birth changes over time, as a result of the effect of our environment on us, even identical twins do not have the same DNA. Because no two people are the same, and no two people experience the same things throughout their life, it’s reasonable to say that each disease behaves differently in each person.

  • 27/07/2016

    The future of personalised medicine lies in your genome

    by Stefano Gortana

    Let’s set aside the complex science of genome sequencing, genetic mutations and comparing genomic datasets for a moment to acknowledge the important overarching fact: we all want better healthcare. This includes not only the early prediction and prevention of disease, but also earlier, more accurate diagnosis followed by a treatment regime tailored specifically to a particular patient, all available at an affordable price. Any developments in science or technology that contribute to the pursuit of these ambitious goals should not only be welcomed, but pursued with rigour. With this undeniable truth established, genomic medicine cannot be ignored.

  • 18/07/2016

    What does the 100,000 Genomes Project mean for patients and the NHS?

    by Stefano Gortana

    The All-Party Parliamentary Group on Personalised Medicine hosted a roundtable meeting in the House of Lords on Wednesday 6 July 2016. The room was filled to capacity with parliamentarians and stakeholders who shared a common interest in the progress and potential impact of the 100,000 Genomes Project.

  • 22/03/2016

    Launch event: exploring personalised medicine

    by Stefano Gortana

    The launch event for the All-Party Parliamentary Group on Personalised Medicine was held on Wednesday 15 March 2016 in the Attlee Suite of Portcullis House. When the presentations began, the room was packed with over 100 professionals representing diverse industries, universities, think tanks and policy institutions, clinical bodies and government parties. 

  • 20/01/2016

    Registration event: unpacking genomics

    by Stefano Gortana

    On 14 December 2015, the All-Party Parliamentary Group on Personalised Medicine held its inaugural meeting, electing its officers and approving the 2016 work programme.

  • 15/12/2015

    Embracing personalised medicine: digital opportunities

    by Hilary Burton (PHG Foundation)

    The UK faces a number of well publicised and intensifying challenges to the effectiveness and sustainability of the NHS. Yet for all the concerns, there should also be hope and an eagerness to capitalise on the rapidly expanding forces for change. Whether you call it the ‘democratisation of healthcare’ or a ‘personalised healthcare revolution’, it is undeniable that individuals are not only taking more control over their own health and care but that digital health technology is rapidly expanding both in terms of popularity and applicability. 

  • 10/12/2015

    Collaborative research to boost health and wealth

    by Hakim Yadi (Northern Health Science Alliance)

    In the last Budget, the Government committed £20m to the Northern Health Science Alliance (NHSA) to deliver the Health North initiative, recognising the value in the Alliance’s collaborative approach to research.

  • 10/12/2015

    A dispatch from the genetic frontier

    by Theo Bloom

    I never thought I had all that much in common with the glamorous film star Angelina Jolie – until May of this year, when she decided to tell the world about her family history of breast cancer, the results of genetic testing, and the decision it led her to take. She wrote poignantly and yet in a matter-of-fact way about the consequences of finding she does carry a BRCA1 mutation that predisposes her to breast and ovarian cancer and deciding to have major preventative surgery so as to reduce her risk of dying prematurely from the disease that killed her mother.

  • 07/05/2015

    Bench to Bedside

    by Sarion Bowers (The Wellcome Trust Sanger Institute)

    The transition from science to technology is not straightforward – great science is not enough to ensure success.